-
27-05-2021, 10:57 AM
#1771
Originally Posted by flyinglizard
market cap, PB and Price to sales ratios, not looking cheap
Compared to what though? Not cheap compared to Metro Glass. Cheap compared to Tesla.
I bought some more at $29. I think if I hold them for 10 years I will likely triple my money.
-
27-05-2021, 10:59 AM
#1772
Not looking cheap, then again never really has (in the past several years at least)... no guidance for FY22 would have really freaked Mr Market out... Mr Market probably thinking that there would be a plunge, perhaps (if not probably) a big plunge, in revenue and NPAT... which would mean FPH goes from being a very expensive stock to an incredibly expensive stock... no debate it was a very sold result for FY21, but FY21 is in the past now and Mr Market is forward looking.
-
27-05-2021, 11:24 AM
#1773
Great result! I'll add a few when the price settles.
-
27-05-2021, 11:26 AM
#1774
Member
Originally Posted by Rawz
Compared to what though? Not cheap compared to Metro Glass. Cheap compared to Tesla.
I bought some more at $29. I think if I hold them for 10 years I will likely triple my money.
compared with MSCI global health care index average PE, PB ratios.
https://www.msci.com/documents/10199...5-703d3bb77ae6
-
27-05-2021, 11:29 AM
#1775
the RBNZ said yesterday rate increases next year so currency people will factor in a stronger dollar going forward , also once covid issues resolve in time less demand ?
carring on before site dropped
but saying that i brought some for a bounce ... seems a bit harsh 10% drop
Last edited by bull....; 27-05-2021 at 12:26 PM.
one step ahead of the herd
-
27-05-2021, 12:27 PM
#1776
The market has always priced FPH highly, who have a history of largely delivering with growth. Bit like MFT, EBO, RYM (in the past) never looked like value but delivered to justify their price.
Now with Covid, a large tail winds, and despite a huge increase in profit, the love affair seems over??? Or has it just cooled a bit?
-
27-05-2021, 12:27 PM
#1777
The market has always priced FPH highly, who have a history of largely delivering with growth. Bit like MFT, EBO, RYM (in the past) never looked like value but delivered to justify their price.
Now with Covid, a large tail winds, and despite a huge increase in profit, the love affair seems over??? Or has it just cooled a bit?
-
27-05-2021, 01:35 PM
#1778
Originally Posted by macduffy
Great result! I'll add a few when the price settles.
Done - at $28.55.
-
27-05-2021, 01:42 PM
#1779
I've always wanted to get on the register for FPH but the SP has always seemed too expensive, finally an opportunity presents itself and i'm onboard . These are getting securely locked in the bottom-draw for the next decade or two.
-
27-05-2021, 01:49 PM
#1780
Me also ended up adding a few around $ 28 ...cant go wrong at these levels ...
Tremendous overreaction as many short term and brokerage lead players freeing their money for better / faster opportunities
Should come back over $ 30 soon IMHO ...still will remain in same trading range for rest of the year I suppose or till more clarity on FY 22 estimates
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks